Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 03-08-2015 | Practice Area: | Corporate and M&A |
| Deal Title: | Shire plc Acquisition of Foresight Biotherapeutics Inc | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised Shire plc in connection with its USD300 million acquisition of Foresight Biotherapeutics Inc. With the acquisition, Shire acquired the global rights to FST-100, a therapy in late-stage development for the treatment of infectious conjunctivitis, an ocular surface condition commonly referred to as pink eye.
The Davis Polk team included partner William J. Chudd.
|
||
| Financial Center: | New York | Value: | 100.01-500.00 |
| Advised Party: | Acquiror | Law Firm | Davis Polk |
| Target Company Jurisdiction: | United States | Acquiror Jurisdiction: | United Kingdom |
| Classification: |
Strategic Buyer Acquisitions Private Company |
Lawyer | William J Chudd |
